Publication | Closed Access

Differences in annual medication costs and rates of dosage increase between tumor necrosis factor-antagonist therapies for rheumatoid arthritis in a managed care population

Annual Medication CostsRheumatologyRheumatoid DisorderDisease ManagementDosage IncreaseHealth EconomicsHealth PolicyRheumatic DiseasesPharmacoeconomicsInflammatory Rheumatic DiseasePharmacotherapyRheumatoid ArthritisHealth Care CostManaged CarePublic HealthMedicineHealth Services ResearchEpidemiology